医学
肾细胞癌
内科学
免疫疗法
不利影响
无容量
肿瘤科
回顾性队列研究
癌症
作者
Praful Ravi,Charlene Mantia,Christopher Su,K Sorenson,Dean Elhag,Nityam Rathi,Ziad Bakouny,Neeraj Agarwal,Yousef Zakharia,Brian A. Costello,Rana R. McKay,Vivek Narayan,Ajjai Alva,Bradley A. McGregor,Xīn Gào,David F. McDermott,Toni K. Choueiri
出处
期刊：JAMA Oncology
[American Medical Association]
日期：2020-05-29
卷期号：6 (10): 1606-1606
被引量：119
标识
DOI：10.1001/jamaoncol.2020.2169
摘要
The findings of this multicenter cohort study suggest that ICI rechallenge in patients with mRCC may be safe and reasonably efficacious, with an overall response rate of 23%. Data from prospective studies are needed to validate these findings and determine the role of sequential ICI regimens in treatment of mRCC.
科研通智能强力驱动
Strongly Powered by AbleSci AI
PDF的下载单位、IP信息已删除
(2025-6-4)
无极微光
大力的灵雁
zzzz
贪玩的秋柔
AllRightReserved
HH
畔畔
lizishu
乐空思
wanci
科研狗
GingerF
浮浮世世
dew
湖工大保卫处
pcr163
昏睡的蟠桃
Mic
Rich
学术文献互助
皖公网安备34019202002308
